News

Scientists Develop Multifunctional Device Which Combines Hemorrhage Treatment and Monitoring Capabilities

(LOS ANGELES) – June 28, 2023 - A multi-faceted device for effectively treating deep, non-compressible, and irregularly-shaped wounds has been engineered by the scientists at the Terasaki Institute for Biomedical Innovation (TIBI). As outlined in their recent paper in Advanced Science, the device provides rapid hemorrhage management, has minimal inflammatory effects, and provides infection control. It also has tunable biodegradation rates, making it usable for both internal and external use, and features sensing capabilities for long-term hemorrhage monitoring. This versatile device is highly beneficial for timely alerts and control of bleeding from surgical wounds, traumatic injuries, and critical illnesses.

Read more ...

Company introduces unique approach to sustainably produced meat

(LOS ANGELES) - The Terasaki Institute for Biomedical Innovation (TIBI) is excited to unveil their first spinout company, Omeat, an organization dedicated to technology for the sustainable production of beef and other meats on a global scale. Omeat produces cultivated meat, using cost-effective, humane, and efficient methods to collect regenerative factors for cell cultivation from healthy, living cows.

Read more ...

(WOODLAND HILLS, CA) – The Terasaki Institute for Biomedical Innovation (TIBI), a non-profit research organization devoted to developing bioengineered systems, devices, and technology for biomedical applications, held a Grand Opening celebration at their newest research facility in Woodland Hills. The event drew almost 100 guests, which included local dignitaries, members of the Terasaki family, TIBI faculty and staff, and members of the building’s design and construction teams.

Read more ...

(LOS ANGELES) - Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have chemically modified titanium dioxide nanoparticles to render them with antimicrobial powers when exposed to both darkness and visible light. These composite nanoparticles, studded with selected chemicals, demonstrated antibacterial and antifungal effectiveness, while serving as models to elucidate the pathways by which these effects are achieved. This opens enticing possibilities for green technology applications, such as wastewater treatment, air purification, or preservation of food. 

Read more ...

Improvements made possible with strategic chemical modifications

(LOS ANGELES) – As part of a collaborative effort, scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have employed inventive chemistry to produce an injectable biomaterial with significantly improved adhesive strength, stretchability, and toughness. This chemically modified, gelatin-based hydrogel had attractive features, including rapid gelation at room temperature and tunable levels of adhesion. This custom-engineered biomaterial is ideal as a surgical wound sealant, with its controllable adhesion and injectability and its superior adherence to a variety of tissue and organ surfaces.

Read more ...

(LOS ANGELES) – Pancreatic ductal adenocarcinoma (PDAC), is highly aggressive and lethal. It is the most prevalent type of pancreatic cancer, making up 90% of cases; it also has a high rate of metastasis, with an average five-year survival rate of less than 10%.

Read more ...